超声造影与增强CT检查诊断原发性肝癌的价值比较研究

doi:10.3969/j.issn.1672-5069.2017.05.037

Abstract

Wang Li，Li Min，Huang Donghua，et al.. Comparative study of diagnostic value of contrast-enhanced ultrasonography and enhanced CT in patients with primary liver cancer[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(5): 627-628.

References

[1] Bartolotta TV，Taibbi A，Picone D，et al. Detection of liver metastases in cancer patients with geographic fatty infiltration of the liver:the added value of contrast-enhanced sonography. Ultrasonography，2017，36（2）:160-169.
[2] 孙亚利，杨勤玲，张毓萍，等.从医院到家庭延续护理对介入治疗中晚期PLC患者负性情绪和生活质量的影响.中国肿瘤临床与康复，2016，23（9）:1119-1121.
[3] 雒大健，张志勇，杨桃，等. 超声造影在PLC介入干预效果评价中的应用价值研究. 中国实验诊断学，2017，21（1）:54-56.
[4] 侯毅斌，王忠富，戴志京，等. PLC介入治疗中磁共振弥散加权成像技术的作用研究. 中国CT和MRI杂志，2015，13（2）:40-42.
[5] 左婷婷，郑荣寿，曾红梅，等. 中国PLC发病状况与趋势分析. 中华肿瘤杂志，2015，37（9）:691-696.
[6] Duran R，Sharma K，Dreher MR，et al. A novel inherently radiopaque bead for transarterial embolization to treat liver cancer-a pre-clinical study.Theranostics，2016，6（1）:28-39.
[7] 雷振武. 门静脉植入放射性支架联合肝动脉化疗栓塞治疗PLC伴门静脉癌栓的疗效评估.中国现代医学杂志，2016，26（23）:111-114.
[8] Hinrichs JB，Shin HO，Kaercher D，et al. Parametric response mapping of contrast-enhanced biphasic CT for evaluating tumour viability of hepatocellular carcinoma after TACE.Eur Radiol，2016，26（10）:3447-3455.
[9] Ladd LM，Tirkes T，Tann M，et al. Comparison of hepatic MDCT，MRI，and DSA to explant pathology for the detection and treatment planning of hepatocellular carcinoma.Clin Mol Hepatol，2016，22（4）:450-457.
[10] 叶桂宏，杨红. 超声造影在PLC射频消融前后的应用价值研究.中国全科医学，2015，18（9）:1090-1093.
[11] 贵传玲. 超声造影技术对原发性PLC介入治疗效果的评估价值.山东医药，2016，56（33）:86-88.
[12] 陈刚，唐晓军，魏强，等.超声造影评价肝动脉化疗栓塞联合微波消融治疗中晚期PLC疗效.东南国防医药，2016，18（5）:531-533，539.
[13] 钟丽云，蒋天安，赵齐羽，等. 影像融合超声造影技术对常规超声及超声造影显示不清PLC的诊治价值.中华超声影像学杂志，2015，24（11）:963-967.
[14] 袁家英，朱红，周智华，等.超声造影技术应用于肝肿瘤介入治疗的临床价值探析.中华临床医师杂志（电子版），2013，7（4）:1479-1482.
[15] 张宏春，耿喆. 增强CT扫描与超声造影对肝脏占位性病变的诊断价值比较. 实用肝脏病杂志，2013,19（6）：696-699.

Comparative study of diagnostic value of contrast-enhanced ultrasonography and enhanced CT in patients with primary liver cancer

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	National Workshop on Fatty Liver, Alcoholic Liver Disease, Chinese Society of Hepatology; National Workshop on Liver, Metabolism, Chinese Society of Endocrinology, Chinese Medical Association. Committee of Hepatology, Chinese Research Hospital Association; Fatty Liver Expert Committee, Chinese Medical Doctor Association [J]. Journal of Practical Hepatology, 2019, 22(6): 787-792.
[2]	. Consensus on the diagnosis and therapy of hepatic fibrosis [J]. Journal of Practical Hepatology, 2019, 22(6): 793-803.
[3]	Cao Ce, Yu Yixing, Wang Beibei, et al.. Clinical diagnostic efficacy of enhanced magnetic resonance imaging combined with serum AFP and PIVKA-Ⅱ in the diagnosis of patients with hepatocellular carcinoma [J]. Journal of Practical Hepatology, 2019, 22(6): 896-899.
[4]	Zeng Yanni, Zhang Can, Bi Junying, et al.. Value of long-time delayed enhancement scan of MRI in the diagnosis of solitary necrotic nodule of liver [J]. Journal of Practical Hepatology, 2019, 22(6): 900-903.
[5]	Ye Xianjun, He Nian’an, Sui Xiufang, et al.. Contrast-enhanced ultrasonographic features of hepatic epitheloid hemangioendothelioma [J]. Journal of Practical Hepatology, 2019, 22(6): 904-907.
[6]	Xing Hao, Han Jun, Yang Tian.. Diagnostic value of serum protein induced by vitamin K absence or antagonist II for hepatocellular carcinoma [J]. Journal of Practical Hepatology, 2019, 22(6): 934-937.
[7]	Liang Jubo, Miao Qi, Ma Xiong.. Diagnosis and treatment of cholangiocytic cholestasis [J]. Journal of Practical Hepatology, 2019, 22(6): 941-943.
[8]	Gao Wei, Hou Yong. Diagnostic efficacy of hepatic fibrosis by liver stiffness measurement in patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 652-655.
[9]	Huang Hanjun, Lu Fengrong, Zhang Can. Clinical value of MRI scanning based on exchange hemodynamics model in evaluating liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 696-699.
[10]	Liu Xing, Zhao Shuli, Zhang Dianlong. Effect of sevoflurane inhalation on hepatic ischemia-reperfusion injury in patients with primary liver cancer undergoing partial hepatectomy [J]. Journal of Practical Hepatology, 2019, 22(5): 728-731.
[11]	Hong Jia, Wu Xiaoning, You Hong. Standardized diagnosis of cholestatic liver diseases [J]. Journal of Practical Hepatology, 2019, 22(5): 758-760.
[12]	Pei Ying, Huang Feng, Yin Hongzhen, et al. Preliminary study on intestinal microecology in mice with xenograft hepatoma intervened by sodiumnorcantharidate [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 486-489.
[13]	Cheng Hua, Ju Hui, Song Deshun et al. Value of serum angiopoietin-like protein 2 and Golgi protein 73 levels in the diagnosis of hepatic fibrosis in patient with chronic hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 494-497.
[14]	Yu Yingfang, Wen Shengbao. Assessment of liver fibrosis with diffusion-weighted magnetic resonance imaging using single, double and stretch index model in patients with chronic hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 502-505.
[15]	Zhang Yafei, Ye Jun, Xie Qinxiu, et al. Difference in predicting efficacy of significant liver fibrosis by noninvasive liver fibrosis index in different hospitals [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 510-513.